Celldex Therapeutics, Inc vs. Idexx Laboratories Inc
Idexx Laboratories Inc (IDXX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CLDX | IDXX | |
|---|---|---|
| Market Cap | $3.02 billion | $39.90 billion |
| Revenue (TTM) | — | $4.55 billion |
| Net Income (TTM) | — | $1.14 billion |
IDXX leads on 1 of 1 size & scale factors.
Valuation
| CLDX | IDXX | |
|---|---|---|
| P/E Ratio | — | 35.96 |
| Price / Book | — | 24.74 |
| Price / Sales | — | 8.76 |
CLDX and IDXX split the valuation factors evenly.
Profitability
| CLDX | IDXX | |
|---|---|---|
| Net Margin | — | 25.03% |
| Return on Equity | — | 70.67% |
CLDX and IDXX split the profitability factors evenly.
Risk & Sentiment
| CLDX | IDXX | |
|---|---|---|
| Short Interest | 9.28% | 1.79% |
IDXX leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, IDXX overview, IDXX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.